Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000488061 | SCV000232366 | uncertain significance | not provided | 2014-12-04 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000488061 | SCV000574803 | uncertain significance | not provided | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001087243 | SCV001107782 | benign | Retinitis pigmentosa 12; Leber congenital amaurosis 8 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Ocular Genomics Institute, |
RCV001376275 | SCV001573358 | likely benign | Retinitis pigmentosa 12 | 2021-04-08 | criteria provided, single submitter | research | The CRB1 c.2462C>T variant was identified in an individual with retinitis pigmentosa with a presumed recessive inheritance pattern. Through a review of available evidence we were able to apply the following criteria: BP4, BS2, PM1, PM3. Based on this evidence we have classified this variant as Likely Benign. |
Genome- |
RCV001563786 | SCV001786813 | uncertain significance | Leber congenital amaurosis 8 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001376275 | SCV001786814 | uncertain significance | Retinitis pigmentosa 12 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV003888637 | SCV004706130 | uncertain significance | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Clinical Genetics, |
RCV000488061 | SCV001919566 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000488061 | SCV001957647 | uncertain significance | not provided | no assertion criteria provided | clinical testing |